Search

Lactobacillus Fermentum Treats Fructose-Related Diseases (EP3768286A1)

EPO published patent application EP3768286A1 on April 8, 2026, covering Lactobacillus fermentum compositions for treating fructose-related diseases. The patent names AixSwiss B.V. as applicant and lists PAULE, Jörg and OESTER, Fabio as inventors. The designation covers 31 European states including all major EU markets.

GAL(1-15) Alcohol Use Disorder Treatment Patent

GAL(1-15) Alcohol Use Disorder Treatment Patent

RSV Vaccine Factsheet – Information for Patients, Parents and Carers

The MHRA published a new patient factsheet on RSV vaccination on 15 April 2026. The factsheet provides comprehensive information about respiratory syncytial virus (RSV), including eligibility criteria, safety and effectiveness of vaccines used in the UK, side effects, pregnancy considerations, and contraindications. The document is designed to help patients, parents, and carers understand RSV vaccines and make informed decisions about vaccination.

Lyophilized Pharmaceutical Compositions for Vaginal Delivery - Catalent EP3525765A1

The EPO published patent application EP3525765A1 for lyophilized pharmaceutical compositions designed for vaginal delivery. The patent was filed by Catalent U.K. Swindon Zydis Limited and names six inventors. The invention covers compositions classified under A61P therapeutic categories including antimicrobials and hormones, designated for protection across 31 European member states.

Tripentadecanoin for Use in Treatment of Retinal or Optic Nerve Degenerative Disease

The European Patent Office published patent application EP3468551A1 for SunRegen Healthcare AG, covering tripentadecanoin for use in treating retinal degenerative diseases or optic nerve degenerative diseases. The patent names DONG Yuhong, CHANG Chun-Hsiung, and LIN Shengtang as inventors. The application is classified under A61K (medicinal preparations) and A61P (therapeutics) with designations extending across 32 European member states.

Overtape Transdermal Delivery System Patent - AdhexPharma

The European Patent Office (EPO) published patent application EP3412283A1 for AdhexPharma SAS covering an overtape for a transdermal delivery system. The patent is designated for all European member states and several additional countries. IPC classifications indicate the technology relates to analgesics (A61P 25/04) and transdermal pharmaceutical delivery (A61K 9/70).

Symrise AG Antimicrobial Compositions, A1 Patent

Symrise AG Antimicrobial Compositions, A1 Patent

Cancer Vaccine Patent hESCs TLR3 Adjuvant Assigned to INSERM

USPTO granted patent US12599662B2 to INSERM for a cancer vaccine composition using irradiated human embryonic stem cells combined with a TLR3 adjuvant. The patent covers methods for treating cancers including breast cancer by inducing MHC-I presentation of antigens. The patent includes 16 claims.

USPTO Patent US12601742B2 for Endometrial Cancer Treatment Methods

USPTO granted patent US12601742B2 to Mayo Foundation for Medical Education and Research covering methods and materials for assessing and treating endometrial cancer. The patent covers methods for identifying endometrial cancers likely to respond to particular cancer treatments by assessing combinations of mutations and expression levels, such as platinum-based therapies. The patent contains 22 claims.

Immunoglobulin Single Variable Domain Antibody Against RSV Prefusion F Protein

The European Patent Office published patent EP3313432A1 for an immunoglobulin single variable domain antibody targeting respiratory syncytial virus (RSV) prefusion F protein. The patent names VIB VZW, Universiteit Gent, the US Department of Health and Human Services, and Dartmouth College as applicants. Six inventors are credited including SAELENS, Xavier and MCLELLAN, Jason. The patent is classified under A61P 31/14 (antivirals) and covers 37 designated European states.